Vanderbilt University Medical Center: Targeted Cancer Drug During Pregnancy
August 03, 2022
August 03, 2022
NASHVILLE, Tennessee, Aug. 3 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
Pregnancy in patients with lung cancer is uncommon. There are limited safety data during pregnancy for ALK inhibitors -- targeted therapies for patients with non-small cell lung cancer (NSCLC) with ALK gene rearrangements.
Wade Iams, MD, MSCI, Travis Osterman, DO, MS, and colleagues report the case of a patient with metastatic ALK-rearranged NSCLC who was treated wit . . .
Pregnancy in patients with lung cancer is uncommon. There are limited safety data during pregnancy for ALK inhibitors -- targeted therapies for patients with non-small cell lung cancer (NSCLC) with ALK gene rearrangements.
Wade Iams, MD, MSCI, Travis Osterman, DO, MS, and colleagues report the case of a patient with metastatic ALK-rearranged NSCLC who was treated wit . . .